Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wiese

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 4, 2012
Expansion of neurofilament medium C terminus increases axonal diameter independent of increases in conduction velocity or myelin thicknessDevin M Barry, William Stevenson, Brian G Bober, et al.
American Journal of Preventive Medicine|April 15, 2008
Web-based smoking-cessation programs: results of a randomized trialVictor J Strecher, Jennifer B McClure, Gwen L Alexander, et al.
Annals of Clinical Biochemistry|October 11, 2022
The association between acid-base status and clinical outcome in critically ill COVID-19 patients admitted to intensive care unit with an emphasis on high anion gap metabolic acidosisAnnalise E Zemlin, Lovemore N Sigwadhi, Owen J Wiese, et al.
International Journal of Molecular Sciences|April 28, 2023
Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal HealingLeonie Wittner, Lukas Wagener, Jakob J Wiese, et al.
American Heart Journal|September 27, 2023
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristicsStephen J Nicholls, Deepak L Bhatt, John B Buse, et al.
Diabetes Care|April 6, 2026
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWINDNaveed Sattar, Hertzel C Gerstein, David D'Alessio, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trialSophia Zoungas, David D'Alessio, Imre Pavo, et al.
The New England Journal of Medicine|December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesStephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Nature Communications|October 21, 2021
Time-resolved relaxation and fragmentation of polycyclic aromatic hydrocarbons investigated in the ultrafast XUV-IR regimeJ W L Lee, D S Tikhonov, P Chopra, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 4, 2012
Expansion of neurofilament medium C terminus increases axonal diameter independent of increases in conduction velocity or myelin thicknessDevin M Barry, William Stevenson, Brian G Bober, et al.
American Journal of Preventive Medicine|April 15, 2008
Web-based smoking-cessation programs: results of a randomized trialVictor J Strecher, Jennifer B McClure, Gwen L Alexander, et al.
Annals of Clinical Biochemistry|October 11, 2022
The association between acid-base status and clinical outcome in critically ill COVID-19 patients admitted to intensive care unit with an emphasis on high anion gap metabolic acidosisAnnalise E Zemlin, Lovemore N Sigwadhi, Owen J Wiese, et al.
International Journal of Molecular Sciences|April 28, 2023
Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal HealingLeonie Wittner, Lukas Wagener, Jakob J Wiese, et al.
American Heart Journal|September 27, 2023
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristicsStephen J Nicholls, Deepak L Bhatt, John B Buse, et al.
Diabetes Care|April 6, 2026
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWINDNaveed Sattar, Hertzel C Gerstein, David D'Alessio, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trialSophia Zoungas, David D'Alessio, Imre Pavo, et al.
The New England Journal of Medicine|December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesStephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Nature Communications|October 21, 2021
Time-resolved relaxation and fragmentation of polycyclic aromatic hydrocarbons investigated in the ultrafast XUV-IR regimeJ W L Lee, D S Tikhonov, P Chopra, et al.
Pageof 16